Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union

Friday, December 18, 2009 Corporate News
Email Print This Page Comment
Font : A-A+

CONTACT:

Amgen, Zug, Switzerland

Marie Fay: +41 (41) 3690 339 (media, osteoporosis)

Sabeena Ahmad: +41 (41) 3692 530 (media, oncology)

Amgen, Thousand Oaks

Kerry Beth Daly: (805) 447-3020 (media, osteoporosis)

Christine Regan: (805) 447-5476 (media, oncology)

John Shutter: (805) 447-1060 (investors)



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook